Press "Enter" to skip to content

New patent for Novartis drug SCEMBLIX

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for SCEMBLIX
Annual Drug Patent Expirations for SCEMBLIX

Scemblix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

This drug has seventy-nine patent family members in forty-nine countries.

The generic ingredient in SCEMBLIX is asciminib hydrochloride. One supplier is listed for this compound. Additional details are available on the asciminib hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

    Leave a Reply

    DrugPatentWatch - Make Better Decisions